Cytokinetics (CYTK)
62.44
-0.42 (0.67%)
Upcoming Events
Latest Headlines
Cytokinetics to Announce Third Quarter Results on November 4, 2026
October 21, 2026 4:00 PM - Globe NewsWire
Form 4 CYTOKINETICS INC For: Oct 16 Filed by: Wysenski Nancy
October 20, 2026 4:36 PM - SEC Filing
Form 4 CYTOKINETICS INC For: Oct 16 Filed by: Kaye Edward M. MD
October 20, 2026 4:35 PM - SEC Filing
Form 4 CYTOKINETICS INC For: Oct 16 Filed by: Harrington Robert Arthur
October 20, 2026 4:34 PM - SEC Filing
Form 4 CYTOKINETICS INC For: Oct 16 Filed by: Daly James M
October 20, 2026 4:32 PM - SEC Filing
Form 4 CYTOKINETICS INC For: Oct 16 Filed by: WIERENGA WENDELL
October 20, 2026 4:31 PM - SEC Filing
Form 4 CYTOKINETICS INC For: Oct 16 Filed by: HENDERSON JOHN T
October 20, 2026 4:29 PM - SEC Filing
Form 144 CYTOKINETICS INC Filed by: Malik Fady Ibraham
October 20, 2026 4:26 PM - SEC Filing
Form 4 CYTOKINETICS INC For: Oct 20 Filed by: Malik Fady Ibraham
October 20, 2026 4:21 PM - SEC Filing
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 19, 2026 4:00 PM - Globe NewsWire
Health Canada approves Cytokinetics' aficamten for heart condition
October 19, 2026 7:31 AM - StreetInsider
Cytokinetics Announces Health Canada Approval of MYQORZO® (aficamten) for the Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy
October 19, 2026 7:30 AM - Globe NewsWire
William Blair Starts Cytokinetics (CYTK) at Outperform
October 15, 2026 4:50 PM - StreetInsider
Cytokinetics (CYTK) PT Lowered to $104 at UBS
October 14, 2026 6:51 AM - StreetInsider
Form 4 CYTOKINETICS INC For: Oct 12 Filed by: Blum Robert I
October 13, 2026 4:01 PM - SEC Filing
Form 144 CYTOKINETICS INC Filed by: Blum Robert I
October 13, 2026 8:20 AM - SEC Filing
Cytokinetics shares new aficamten data for non-obstructive HCM
October 12, 2026 4:03 PM - StreetInsider
Cytokinetics Announces Additional Data from ACACIA-HCM Presented at the HFSA Annual Scientific Meeting 2026
October 12, 2026 4:00 PM - Globe NewsWire
Cytokinetics (CYTK) PT Raised to $113 at RBC Capital
October 8, 2026 8:27 AM - StreetInsider
Form 4 CYTOKINETICS INC For: Oct 06 Filed by: Malik Fady Ibraham
October 6, 2026 4:25 PM - SEC Filing
Cytokinetics Announces Four Upcoming Presentations at the HFSA Annual Scientific Meeting 2026
October 2, 2026 7:30 AM - Globe NewsWire
Cytokinetics launches real-world study of aficamten in heart disease
September 30, 2026 7:31 AM - StreetInsider
Cytokinetics Launches ASPEN-HCM: A Real-World Study Evaluating MYQORZO® (aficamten) in Symptomatic Obstructive Hypertrophic Cardiomyopathy
September 30, 2026 7:30 AM - Globe NewsWire
Form 4 CYTOKINETICS INC For: Sep 28 Filed by: Blum Robert I
September 28, 2026 4:55 PM - SEC Filing
Form 4 CYTOKINETICS INC For: Sep 22 Filed by: Malik Fady Ibraham
September 22, 2026 6:15 PM - SEC Filing
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 17, 2026 4:00 PM - Globe NewsWire
Form 144 CYTOKINETICS INC Filed by: Blum Robert I
September 15, 2026 5:51 PM - SEC Filing
Form 4 CYTOKINETICS INC For: Sep 15 Filed by: Landry Robert E
September 15, 2026 5:23 PM - SEC Filing
Form 4 CYTOKINETICS INC For: Sep 14 Filed by: Blum Robert I
September 15, 2026 5:21 PM - SEC Filing
Cytokinetics Announces Call for Proposals for Ninth Annual Communications Grant Program
September 14, 2026 7:30 AM - Globe NewsWire
Form 4 CYTOKINETICS INC For: Sep 11 Filed by: Landry Robert E
September 11, 2026 7:13 PM - SEC Filing
Form 144 CYTOKINETICS INC Filed by: Landry Robert E
September 11, 2026 4:30 PM - SEC Filing
Cytokinetics (CYTK) Reiterated at Overweight by Cantor Fitzgerald
September 11, 2026 7:26 AM - StreetInsider
Truist Securities Reiterates Buy Rating on Cytokinetics (CYTK)
September 1, 2026 3:56 AM - StreetInsider
Cytokinetics aficamten shows cardiac benefits in two HCM trial analyses
August 31, 2026 6:05 AM - StreetInsider
Cytokinetics Announces Additional Results from ACACIA-HCM and MAPLE-HCM Presented in Late Breaking Clinical Trial Session at the European Society of Cardiology (ESC) Congress 2026
August 29, 2026 10:30 AM - Globe NewsWire
Form 8-K CYTOKINETICS INC For: Aug 28
August 28, 2026 9:22 AM - SEC Filing
Cytokinetics aficamten meets dual endpoints in non-obstructive HCM trial
August 28, 2026 5:51 AM - StreetInsider
Cytokinetics Announces Positive Results from ACACIA-HCM Presented in Hot Line Session at the European Society of Cardiology (ESC) Congress 2026 and Published in The New England Journal of Medicine
August 28, 2026 5:45 AM - Globe NewsWire
Cytokinetics Announces Upcoming Presentations at the European Society of Cardiology (ESC) Congress 2026
August 20, 2026 7:30 AM - Globe NewsWire
Form 4 CYTOKINETICS INC For: Aug 18 Filed by: Malik Fady Ibraham
August 18, 2026 4:38 PM - SEC Filing
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 18, 2026 4:00 PM - Globe NewsWire
Form 8-K CYTOKINETICS INC For: Aug 13
August 17, 2026 9:01 AM - SEC Filing
H.C. Wainwright Reiterates Buy Rating on Cytokinetics (CYTK)
August 14, 2026 6:46 AM - StreetInsider
Form SCHEDULE 13G/A CYTOKINETICS INC Filed by: WELLINGTON MANAGEMENT GROUP LLP
August 13, 2026 4:10 PM - SEC Filing
Cytokinetics sues Bristol-Myers Squibb over aficamten patent dispute
August 13, 2026 9:26 AM - StreetInsider
Form 8-K CYTOKINETICS INC For: Aug 13
August 13, 2026 9:25 AM - SEC Filing
Cytokinetics (CYTK) PT Raised to $103 at JPMorgan
August 13, 2026 9:08 AM - StreetInsider
Cytokinetics (CYTK) PT Raised to $110 at Barclays
August 13, 2026 6:15 AM - StreetInsider
Form 4 CYTOKINETICS INC For: Aug 10 Filed by: Blum Robert I
August 10, 2026 5:12 PM - SEC Filing
Cytokinetics (CYTK) PT Raised to $112 at Truist Securities
August 10, 2026 7:21 AM - StreetInsider
Cytokinetics (CYTK) PT Lowered to $112 at RBC Capital
August 7, 2026 7:15 AM - StreetInsider
Cytokinetics (CYTK) PT Raised to $110 at Citizens on Strong MYQORZO Launch
August 7, 2026 6:01 AM - StreetInsider
Cytokinetics (CYTK) Tops Q2 EPS by 13c
August 6, 2026 4:59 PM - StreetInsider
Form 10-Q CYTOKINETICS INC For: Jun 30
August 6, 2026 4:37 PM - SEC Filing
Form 8-K CYTOKINETICS INC For: Aug 06
August 6, 2026 4:17 PM - SEC Filing
Cytokinetics Reports Second Quarter 2026 Financial Results and Provides Business Update
August 6, 2026 4:00 PM - Globe NewsWire
Form 4 CYTOKINETICS INC For: Jul 30 Filed by: Callos Andrew
July 30, 2026 4:26 PM - SEC Filing
Form 144 CYTOKINETICS INC Filed by: Callos Andrew
July 30, 2026 4:23 PM - SEC Filing
Cytokinetics wins UK approval for heart drug aficamten
July 30, 2026 6:21 AM - StreetInsider
Cytokinetics Announces MHRA Marketing Authorisation for MYQORZO®▼ (aficamten) and Positive Guidance from NICE for Symptomatic Obstructive Hypertrophic Cardiomyopathy in England and Wales
July 30, 2026 6:20 AM - Globe NewsWire
Form 4 CYTOKINETICS INC For: Jul 27 Filed by: Blum Robert I
July 27, 2026 4:34 PM - SEC Filing
Full Article List
